InMed Pharmaceuticals
11 hedge funds and large institutions have $877K invested in InMed Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$341K | |
| 2 | +$101K | |
| 3 | +$91K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$45K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$38K |
Top Sellers
| 1 | -$23K | |
| 2 | -$23K | |
| 3 | -$6K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$5K |